| Page 1787 | Kisaco Research
 

Durhane Wong-Riefer

President & CEO
Canadian Organization for Rare Diseases

Durhane Wong-Riefer

President & CEO
Canadian Organization for Rare Diseases

Durhane Wong-Riefer

President & CEO
Canadian Organization for Rare Diseases
 

Tom Defay

Director, Data Sciences, Genomics, and Bioinformatics
Chief Commercial Officer

Tom Defay

Director, Data Sciences, Genomics, and Bioinformatics
Chief Commercial Officer

Tom Defay

Director, Data Sciences, Genomics, and Bioinformatics
Chief Commercial Officer
 

Christina Hartman

Senior Director, Advocacy & Policy
EveryLife Foundation for Rare Diseases

Christina Hartman

Senior Director, Advocacy & Policy
EveryLife Foundation for Rare Diseases

Christina Hartman

Senior Director, Advocacy & Policy
EveryLife Foundation for Rare Diseases
 

Anne Young PhD

Technical Service Specialist - Bioactives
BASF

Anne Young PhD

Technical Service Specialist - Bioactives
BASF

Anne Young PhD

Technical Service Specialist - Bioactives
BASF

 

Dr. Jean-Paul Pirnay

Head of the Laboratory for Molecular and Cellular Technology
Queen Astrid Military Hospital

Dr. Jean-Paul Pirnay

Head of the Laboratory for Molecular and Cellular Technology
Queen Astrid Military Hospital

Dr. Jean-Paul Pirnay

Head of the Laboratory for Molecular and Cellular Technology
Queen Astrid Military Hospital
 

Michel de Baar

Executive Director, BD&L Europe
MSD

Michel de Baar

Executive Director, BD&L Europe
MSD

Michel de Baar

Executive Director, BD&L Europe
MSD
 

Lorenzo Corsini MD

Managing Director
BioNTech, R&D Austria

Lorenzo Corsini MD

Managing Director
BioNTech, R&D Austria

Lorenzo Corsini MD

Managing Director
BioNTech, R&D Austria
 

Dr. Bob Blasdel

Research Director
Vesale Pharma

I work as the Research Director for Vésale Bioscience where I contribute my ten years’ experience in the phage therapy field as well as my expertise in the biology of phages on a microbiological, molecular, structural, multi‘-omics’, and regulatory level. We work on progressing the personalized model of phage therapy, developing and manufacturing phages as APIs for magistral preparations according to the European model of phage therapy.

Dr. Bob Blasdel

Research Director
Vesale Pharma

Dr. Bob Blasdel

Research Director
Vesale Pharma

I work as the Research Director for Vésale Bioscience where I contribute my ten years’ experience in the phage therapy field as well as my expertise in the biology of phages on a microbiological, molecular, structural, multi‘-omics’, and regulatory level. We work on progressing the personalized model of phage therapy, developing and manufacturing phages as APIs for magistral preparations according to the European model of phage therapy.

I spend a lot of time thinking about what I'm going to eat next, why cows tend to orient themselves on a north/south axis, whether viruses are alive or non-living (or undead!), what it could have really been like to have lived under the laws of Solon, structure/function arguments in biology, and the value that I like to pretend the Oxford comma has for ameliorating run-on sentences.

 

Dr. Krystyna Dabrowska

Phage Biologist
Bacteriophage Laboratory, Polish Academy of Sciences

Dr. Krystyna Dabrowska

Phage Biologist
Bacteriophage Laboratory, Polish Academy of Sciences

Dr. Krystyna Dabrowska

Phage Biologist
Bacteriophage Laboratory, Polish Academy of Sciences